22 research outputs found
The 21-item Barratt Impulsiveness Scale Revised (BIS-R-21): an alternative three-factor model
Background and aims: Due to its important role in both healthy groups and those with physical, mental and behavioral disorders, impulsivity is a widely researched construct. Among various self-report questionnaires of impulsivity, the Barratt Impulsiveness Scale is arguably the most frequently used measure. Despite its international use, inconsistencies in the suggested factor structure of its latest version, the BIS-11, have been observed repeatedly in different samples. The goal of the present study was therefore to test the factor structure of the BIS-11 in several samples.
Methods: Exploratory and confirmatory factor analyses were conducted on two representative samples of Hungarian adults (N 5 2,457; N 5 2,040) and a college sample (N 5 765).
Results: Analyses did not confirm the original model of the measure in any of the samples. Based on explorative factor analyses, an alternative three-factor model (cognitive impulsivity; behavioral impulsivity; and impatience/ restlessness) of the Barratt Impulsiveness Scale is suggested. The pattern of the associations between the three factors and aggression, exercise, smoking, alcohol use, and psychological distress supports the construct validity of this new model.
Discussion: The new measurement model of impulsivity was confirmed in two independent samples. However, it requires further cross-cultural validation to clarify the content of self-reported impulsivity in both clinical and nonclinical samples
Recommended from our members
Voices of temporary sobriety - a diary study of an alcohol-free month in Hungary
Background: Temporary abstinence from alcohol as a challenge could support self-knowledge, self-care, and health consciousness in several ways.
Objectives: The present study explored Dry November participants’ personal experiences and coping strategies during a one-month abstinence period. The research is embedded in the Hungarian context of drinking habits, culture, society, and alcohol policy.
Methods: This qualitative study comprised the thematic analysis of 23 participants’ diaries, reported twice a week for 30 days (in November 2017), to identify and understand the common experiences of temporary sobriety.
Results: Three main themes emerged from the analysis: challenge, community, and relationship toward alcohol and abstinence. Results showed that there are no categorical differences between successful and non-successful participants.
Conclusions: The present research demonstrated that during the challenge, rather than simply saying ‘no’ to alcohol, participants utilized other refusal strategies to avoid social confrontation
A comprehensive overview on Kratom
Kratom (Mitragyna speciosa Korth) is a tropical tree, indigenous to South East Asia. Historically, the plant is locally used as a stimulant, a remedy in traditional medicine and in social context. Imported to Western countries, Kratom is classified as a novel psychoactive substance (NPS). A systematic review of the literature on Mitragyna speciosa and its main constituents was carried by our international multidisciplinary group. Results were qualitatively analysed in three main areas of interest: in-vitro and preclinical data on pharmacology and behavioral effects, laboratoristic techniques for identification/characterization, epidemiological/toxicological reports on humans. At present, there is no systematic data on the prevalence of Kratom use in all the native countries, but it seems to be considerable. In South-East Asia, Kratom, even if banned, might be still considered a better option than other illicit drugs, an alternative opioid treatment, a “natural” remedy with no real social stigma attached to its consumption. In parallel, this ethno-drug seems to be popular in Western countries, largely unregulated, easily available on the Internet. Kratom pharmacology appears to be complex, with many alkaloids involved. The subjective effects in humans are very peculiar and seem to be dose-dependent, ranging from psycho-stimulant to sedative-narcotic. Available data on Kratom suggest caution: this psychoactive plant could exhibit a serious harmful potential. Kratom use seems to be associated with drug dependency, development of withdrawal symptoms, craving, serious adverse effects and life-threatening effects in a multidrug-intoxicating scenario. On the other hand, its anxyiolitic, antidepressant and analgesic properties deserve to be further studied
Why do people use new psychoactive substances? Development of a new measurement tool in six European countries.
This study was supported by the European Union (New Psychoactive Substances: transnational project on different user groups, user characteristics, extent and patterns of use, market dynamics, and best practices in prevention [HOME/2014/JDRU/AG/DRUG/7077]), the Hungarian National Research, Development and Innovation Office (Grant number: KKP126835; NKFIH1157-8/2019-DT). The study was also supported for the realization of this international cofinanced science project in 2016-2017 by the Polish Ministry of Science and Higher Education. Máté Kapitány-Fövény acknowledges the support by the János Bolyai Research Scholarship of the Hungarian Academy of Sciences and the support by the ÚNKP-19 New National Excellence Program of the Hungarian Ministry for Innovation and Technology. The funding institutions had no role in the study design or the collection, analysis and interpretation of the data, writing the manuscript, or the decision to submit the paper for publication
Substance use and psychological disorders among art and non-art university students: an empirical self-report survey
Media stories often suggest that those working in the creative arts appear to use and abuse psychoactive substances. The aim of the present study was to analyze the relationship between the use of psychoactive substances and the presence of psychological disorders among art and non-art students. Questionnaires related to these two areas were completed by 182 art students in higher education and a control group of 704 non-art university students. To assess psychoactive substance use, a structured questionnaire including the Cannabis Abuse Screening Test (CAST) and the Alcohol Use Disorders Identification Test (AUDIT) was administered to participants. Psychological disorders were assessed using the Hungarian version of the Brief Symptom Inventory (BSI) and the Global Severity Index (GSI). After analyzing the data, significant differences were found between the two groups regarding their first use of psychoactive substances. Art students' current substance use was found to be significantly more frequent compared to the control group. In relation to psychological disorders, art students scored significantly higher on three scales of the BSI (i.e., psychoticism, hostility, and phobic anxiety). Overall, a significantly higher proportion of artists were labeled as "problematic" using the GSI. The results suggest that artists have a higher risk of both substance use and experiencing psychological disorders
International consensus statement for the screening, diagnosis, and treatment of adolescents with concurrent Attention-Deficit/Hyperactivity Disorder and substance use disorder
Education and Child Studie
The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study
Abstract
Background: Substance use disorders (SUD) often co-occur with attention deficit hyperactivity disorder (ADHD).
Although the short-term effects of some specific interventions have been investigated in randomized clinical trials, little is known about the long-term clinical course of treatment-seeking SUD patients with comorbid ADHD.
Aims: This paper presents the protocol and baseline clinical characteristics of the International Naturalistic Cohort
Study of ADHD and SUD (INCAS) designed and conducted by the International Collaboration on ADHD and Substance
Abuse (ICASA) foundation. The overall aim of INCAS is to investigate the treatment modalities provided to
treatment-seeking SUD patients with comorbid ADHD, and to describe the clinical course and identify predictors for
treatment outcomes. This ongoing study employs a multicentre observational prospective cohort design. Treatment-seeking adult SUD patients with comorbid ADHD are recruited, at 12 study sites in nine different countries. During the follow-up period of nine months, data is collected through patient files, interviews, and self-rating scales, targeting a broad range of cognitive and clinical symptom domains, at baseline, four weeks, three months and nine months.
Results: A clinically representative sample of 578 patients (137 females, 441 males) was enrolled during the recruitment
period (June 2017-May 2021). At baseline, the sample had a mean age (SD) of 36.7 years (11.0); 47.5% were inpatients
and 52.5% outpatients; The most prevalent SUDs were with alcohol 54.2%, stimulants 43.6%, cannabis 33.1%, Abstract
Background: Substance use disorders (SUD) often co-occur with attention deficit hyperactivity disorder (ADHD).
Although the short-term effects of some specific interventions have been investigated in randomized clinical trials,
little is known about the long-term clinical course of treatment-seeking SUD patients with comorbid ADHD.
Aims: This paper presents the protocol and baseline clinical characteristics of the International Naturalistic Cohort
Study of ADHD and SUD (INCAS) designed and conducted by the International Collaboration on ADHD and Substance
Abuse (ICASA) foundation. The overall aim of INCAS is to investigate the treatment modalities provided to
treatment-seeking SUD patients with comorbid ADHD, and to describe the clinical course and identify predictors for
treatment outcomes.
This ongoing study employs a multicentre observational prospective cohort design. Treatment-seeking adult SUD
patients with comorbid ADHD are recruited, at 12 study sites in nine different countries. During the follow-up period
of nine months, data is collected through patient files, interviews, and self-rating scales, targeting a broad range of
cognitive and clinical symptom domains, at baseline, four weeks, three months and nine months.
Results: A clinically representative sample of 578 patients (137 females, 441 males) was enrolled during the recruitment
period (June 2017-May 2021). At baseline, the sample had a mean age (SD) of 36.7 years (11.0); 47.5% were inpatients
and 52.5% outpatients; The most prevalent SUDs were with alcohol 54.2%, stimulants 43.6%, cannabis 33.1%, and opioids 14.5%. Patients reported previous treatments for SUD in 71.1% and for ADHD in 56.9%. Other comorbid mental disorders were present in 61.4% of the sample: major depression 31.5%, post-traumatic stress disorder 12.1%, borderline personality disorder 10.2%. Conclusions: The first baseline results of this international cohort study speak to its feasibility. Data show that many SUD patients with comorbid ADHD had never received treatment for their ADHD prior to enrolment in the study.
Future reports on this study will identify the course and potential predictors for successful pharmaceutical and psychological
treatment outcomes
Synthetic Cathinones—Prevalence and Motivations for Use
This book chapter reviews the prevalence and motivations for use of synthetic cathinones with respect to their availability, legal status, numbers and seized amounts